BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30283265)

  • 1. Clinical Lifestyle Medicine Strategies for Preventing and Reversing Memory Loss in Alzheimer's.
    Shetty P; Youngberg W
    Am J Lifestyle Med; 2018; 12(5):391-395. PubMed ID: 30283265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review.
    Rao RV; Subramaniam KG; Gregory J; Bredesen AL; Coward C; Okada S; Kelly L; Bredesen DE
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline.
    Rao RV; Kumar S; Gregory J; Coward C; Okada S; Lipa W; Kelly L; Bredesen DE
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Study: A Precision Medicine Approach to Multifactorial Dementia and Alzheimer's Disease.
    Ross MK; Raji C; Lokken KL; Bredesen DE; Roach JC; Funk CC; Price N; Rappaport N; Hood L; Heath JR
    J Alzheimers Dis Parkinsonism; 2021; 11(Suppl 5):. PubMed ID: 35237464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Coaching for Cognition in Alzheimer's (COCOA) trial: Study design.
    Roach JC; Hara J; Fridman D; Lovejoy JC; Jade K; Heim L; Romansik R; Swietlikowski A; Phillips S; Rapozo MK; Shay MA; Fischer D; Funk C; Dill L; Brant-Zawadzki M; Hood L; Shankle WR
    Alzheimers Dement (N Y); 2022; 8(1):e12318. PubMed ID: 35910672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulus-induced gamma rhythms are weaker in human elderly with mild cognitive impairment and Alzheimer's disease.
    Murty DV; Manikandan K; Kumar WS; Ramesh RG; Purokayastha S; Nagendra B; Ml A; Balakrishnan A; Javali M; Rao NP; Ray S
    Elife; 2021 Jun; 10():. PubMed ID: 34099103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of multidomain lifestyle interventions on cognitive decline and Alzheimer's disease prevention: A literature review and future recommendations.
    Noach S; Witteman B; Boss HM; Janse A
    Cereb Circ Cogn Behav; 2023; 4():100166. PubMed ID: 37215433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review.
    Freudenberg-Hua Y; Li W; Davies P
    Front Med (Lausanne); 2018; 5():108. PubMed ID: 29740579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
    Sherman DS; Mauser J; Nuno M; Sherzai D
    Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.